Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
InNeuroCo
AddedFeb 16, 2024
UpdatedJun 18, 2026
InNeuroCo

InNeuroCo

Acquired

InNeuroCo: Innovating in healthcare with advanced medical devices for complex tasks.

HQ
Pembroke Pines, FL, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize the neurovascular industry, InNeuroCo focuses on creating and delivering high-quality complex catheter solutions. The company dedicates significant time and resources to designing and developing safe, innovative medical devices that address challenging tasks in healthcare. Their products are tailored for use by industry leaders and doctors, ensuring they meet the highest standards of approval and effectiveness.

InNeuroCo has become part of Integer, a notable affiliation that underscores its credibility and potential for growth. The company has achieved recognition for its cutting-edge technology and commitment to advancing neurovascular care. Through its innovative solutions, InNeuroCo has made a significant impact on the medical device industry, enhancing the quality of care for patients with complex neurovascular conditions.

InNeuroCo - Similar Companies

Neurvana Medical logo

Neurvana Medical

Neuro42 logo

Neuro42

BrainHealth logo

BrainHealth

Nico logo

Nico

niconeuro.com

NeuroVasc Technologies logo

NeuroVasc Technologies

Rist Neurovascular logo

Rist Neurovascular

ristneuro.com

Mivi Neuroscience logo

Mivi Neuroscience

mivineuro.com

NeuRx Medical logo

NeuRx Medical

neurxmed.com

NeuroBionics logo

NeuroBionics

ClearPoint Neuro logo

ClearPoint Neuro

Neuro Kinetics logo

Neuro Kinetics

Progressive Nuero logo

Progressive Nuero

Galaxy Therapeutics logo

Galaxy Therapeutics

Neuroptics logo

Neuroptics

neuroptics.com

Epic Neuro logo

Epic Neuro

InNeuroCo - Quick Facts

Who are InNeuroCo's competitors?

Companies similar to InNeuroCo include Neurvana Medical, Neuro42, BrainHealth and Nico.

When was InNeuroCo founded?

InNeuroCo was founded in 2014.

Where is InNeuroCo's headquarters located?

InNeuroCo's headquarters is located in Pembroke Pines, FL, US.

When was InNeuroCo's last funding round?

InNeuroCo's most recent funding round was for $287.1k (USD) in September 2020.

How much has InNeuroCo raised to-date?

As of Sep 8, 2020, InNeuroCo has raised a total of $867.2k (USD).

InNeuroCo - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Robotics
Geographic Exposure
  • Americas
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified